Education
About Us
Working with TipRanks
Follow Us
Athira Pharma (ATHA)
NASDAQ:ATHA
Total Valuation
Athira Pharma has a market cap or net worth of $9.34M. The enterprise value is -$27.24M.
Market Cap$9.34M
Enterprise Value-$27.24M
Share Statistics
Athira Pharma has 39.04M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39.04M
Owened by Insiders10.49%
Owened by Instutions31.98%
Financial Efficiency
Athira Pharma’s return on equity (ROE) is -2.16 and return on invested capital (ROIC) is -219.08%.
Return on Equity (ROE)-216.19%
Return on Assets (ROA)-164.92%
Return on Invested Capital (ROIC)-219.08%
Return on Capital Employed (ROCE)-221.06%
Revenue Per Employee$0
Profits Per Employee-$3,728,461.538
Employee Count26
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Athira Pharma is -0.23. Athira Pharma’s PEG ratio is 0.01.
PE Ratio-0.23
PS Ratio0.00
PB Ratio0.50
Price to Fair Value0.50
Price to FCF-0.23
Price to Operating Cash Flow-0.23
PEG Ratio0.01
Income Statement
In the last 12 months, Athira Pharma had revenue of $0.00 and earned -$96.94M in profits. Earnings per share was -$2.53.
Revenue$0.00
Gross Profit-$484.00K
Operating Income-$100.90M
Pretax Income-$96.94M
Net Income-$96.94M
EBITDA-95.81M
Earnings Per Share (EPS)-2.53
Cash Flow
In the last 12 months, operating cash flow was -$97.17M and capital expenditures -$33.00K, giving a free cash flow of -$97.20M billion.
Operating Cash Flow-$97.17M
Free Cash Flow-$97.20M
Free Cash Flow per Share-$2.49
Dividends & Yields
Athira Pharma pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-430.55%
Earnings Yield-429.38%
Stock Price Statistics
Beta1.99
52-Week Price Change-87.86%
50-Day Moving Average0.37
200-Day Moving Average1.11
Relative Strength Index (RSI)27.60
Average Volume (3m)195.65K
Important Dates
Athira Pharma upcoming earnings date is May 8, 2025, After Close.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Athira Pharma as a current ratio of 4.18, with Debt / Equity ratio of 0.03
Current Ratio4.18
Quick Ratio4.18
Debt to Market Cap0.05
Net Debt to EBITDA0.47
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Athira Pharma has paid $198.72K in taxes.
Income Tax$198.72K
Effective Tax Rate0.00%
Enterprise Valuation
Athira Pharma EV to EBITDA ratio is 0.24, with an EV/FCF ratio of 0.25.
EV to Sales0.00
EV to EBITDA0.24
EV to Free Cash Flow0.25
EV to Operating Cash Flow0.25
Balance Sheet
Athira Pharma has $51.27M in cash and marketable securities with $1.22M in debt, giving a net cash position of -$50.06M billion.
Cash & Marketable Securities$51.27M
Total Debt$1.22M
Net Cash-$50.06M
Net Cash Per Share-$1.28
Tangible Book Value Per Share$1.17
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Athira Pharma is , which is 11.43% higher than the current price. The consensus rating is Hold
Price Target
Price Target Upside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast18.61%